Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.47 USD | -7.26% | -6.91% | +203.54% |
Business Summary
Number of employees: 253
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Oligonucleotide Conjugates
100.0
%
| 9 | 100.0 % | 10 | 100.0 % | +3.64% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 10 | 100.0 % | +3.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Troy Wilson
FOU | Founder | 55 | 12-11-12 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 19-09-30 |
Michael MacLean
DFI | Director of Finance/CFO | 58 | 20-05-18 |
Steven G. Hughes
CTO | Chief Tech/Sci/R&D Officer | 57 | 22-02-22 |
W. Flanagan
CTO | Chief Tech/Sci/R&D Officer | 62 | 21-01-20 |
Arthur Levin
BRD | Director/Board Member | 70 | 13-09-30 |
Teresa McCarthy
HRO | Human Resources Officer | 60 | 20-07-31 |
Corporate Officer/Principal | - | 21-03-31 | |
Corporate Officer/Principal | 46 | 21-08-24 | |
John W. Wallen
LAW | General Counsel | 66 | 12-11-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 13-09-30 |
Carsten Boess
BRD | Director/Board Member | 57 | 20-04-12 |
Edward Kaye
BRD | Director/Board Member | 75 | 19-08-21 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 19-09-30 |
Jean Kim
BRD | Director/Board Member | 50 | 21-01-10 |
Troy Wilson
FOU | Founder | 55 | 12-11-12 |
Corporate Officer/Principal | 46 | 21-08-24 | |
Noreen Henig
BRD | Director/Board Member | 59 | 19-08-21 |
Tamar Thompson
BRD | Director/Board Member | 50 | 21-01-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 95,636,748 | 90,173,266 ( 94.29 %) | 0 | 94.29 % |
Company contact information
Avidity Biosciences, Inc.
10578 Science Center Drive Suite 125
92121, San Diego
+
http://www.aviditybiosciences.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+219.12% | 2.83B | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-15.45% | 32.79B | |
+63.37% | 26.23B | |
-21.70% | 14.52B | |
-7.63% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+5.24% | 8.82B |
- Stock Market
- Equities
- RNA Stock
- Company Avidity Biosciences, Inc.